United States· US:66794-251_58ee3114-2876-e1e7-e063-6294a90a87c2
Erythromycin Lactobionate
A medicinal product containing erythromycin lactobionate, registered in United States by Piramal Critical Care Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ERYTHROMYCIN LACTOBIONATE
- Manufacturer
- Piramal Critical Care Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- August 16, 2026
Packs & prices · 1
- ndc1166794-251-41
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Erythromycin lactobionate in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomErythrocin IV lactobionate 1g powder for solution for infusion vialsAdvanz Pharma
- FinlandAbboticinOrifarm Oy
- GermanyErythrocin-I.V.Amdipharm Limited
- BelgiumErythrocine IV 1 gAmdipharm
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Austria · Erythrocin - Lactobionat
- Cyprus · Erythromycin I.V. Inresa
- Germany · Erythrocin-I.V., Erythromycin Inresa
- Spain · Pantomicina
- France · Erythrocine
- United Kingdom (Northern Ireland) · Erythrocin I.V. Lactobionate, Erythromycin Lactobionate Amdipharm Uk
- Ireland · Erythrocin Iv Lactobionate
- Italy · Eritromicina Lattobionato Fisiopharma
- Norway · Abboticin
- Portugal · Eritrocel
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d4976aac-bde7-4a30-a91e-308cdf08b975 GET /v1/drugs/d4976aac-bde7-4a30-a91e-308cdf08b975?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "500",
"substance": "ERYTHROMYCIN LACTOBIONATE",
"productndc": "66794-251",
"dosage_form": "INJECTION, POWDER, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA216761",
"marketing_category": "ANDA"
}See everything about erythromycin lactobionate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.